ADTRALZA ADVOCATE
DEAD

Serial Number

90507944

Owner

LEO PHARMA A/S

Attorney

B. Brett Heavner

Filing Date

Feb 3, 2021

Add to watchlist:

No watchlists yet
View on USPTO

ADTRALZA ADVOCATE Trademark

Serial Number: 90507944

ADTRALZA ADVOCATE is a trademark filed by LEO PHARMA A/S on February 3, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 38 (Telecommunications), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

LEO PHARMA A/S (123 trademarks)

IDUSTRIPARKEN 55
BALLERUP DK-2750 , DK

Entity Type: 03

Trademark Details

Filing Date

February 3, 2021

Registration Date

Not Registered

Published for Opposition

November 2, 2021

Goods & Services

Providing online forums for information and communication about skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin

Pharmaceutical and medical preparations for treatment of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and for treatment of the skin

Medical testing for diagnostic or treatment purposes, in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin; medical services in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin; medical, health and pharmaceutical consultation services in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin

Scientific and medical research in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin; research and development services and scientific research and testing of pharmaceuticals, all in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin; providing information and consulting services in the field of research and development services and scientific research in relation to skin diseases and treatment of the skin; testing of pharmaceuticals in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Aug 1, 2022 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Aug 1, 2022 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 28, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 2, 2021 NPUB
PUBLISHED FOR OPPOSITION
Nov 2, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 13, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 30, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 29, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 29, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 29, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 26, 2021 GNRN
NON-FINAL ACTION E-MAILED
Aug 26, 2021 GNRT
NON-FINAL ACTION WRITTEN
Aug 26, 2021 CNRT
ASSIGNED TO EXAMINER
Aug 25, 2021 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 7, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 6, 2021 NWOS
NEW APPLICATION ENTERED
Feb 6, 2021 NWAP